Ultrahuman in Advanced Talks to Raise $120 Mn from WestBridge, Valuation Set to Quadruple

The new capital is expected to fuel the start-up’s rapid international expansion and product innovation push, including new wearable devices, clinical trials in fertility and cardiovascular health.

Bengaluru-based healthtech startup Ultrahuman has entered advanced discussions to raise over $120 million in fresh funding, led by WestBridge Capital.

Reportedly, this funding could catapult the company’s valuation to around $550–600 million, nearly a fourfold jump from its $125 million valuation in March 2024.

The new capital is expected to fuel the start-up’s rapid international expansion and product innovation push, including new wearable devices, clinical trials in fertility and cardiovascular health, and the ramp-up of its US-based UltraFactory in Indiana.

The Financial Tea

The funding talks come after Ultrahuman’s earlier negotiations with Japanese investor SoftBank for a $40 million round fell through over valuation and deal size differences. 

Since then, the start-up has posted a sharp financial upswing, closing 2024 with around $74 million in revenue, a sixfold jump year-on-year, and is now tracking an annualised run-rate of $150–160 million, according to sources familiar with the matter.

The development was first reported by Moneycontrol.

Founded in 2019 by Mohit Kumar and Vatsal Singhal, Ultrahuman has rapidly expanded its footprint from two countries in 2023 to over 10 markets by the end of 2024, buoyed by a growing portfolio of smart wearable devices and metabolic health services. 

In March 2024, Ultrahuman closed a $35 million round at a $125 million valuation, backed by Blume Ventures, Nexus Venture Partners, Alpha Wave Global, and Deepinder Goyal. This latest round signals how dramatically the company’s fortunes and investor confidence have shifted in under a year.

Stay tuned for more such updates on Digital Health News.